Does retatrutide lose effectiveness over time?

This site holds no study on one person losing the effect, or on a date when retatrutide fades. What it holds is how long studies ran. In TRIUMPH-1, with 2,339 people, a company release reported up to 28.3% average weight loss at 80 weeks on 12 milligrams, versus 2.2% on a dummy shot. An earlier study ran 48 weeks in 338 adults, with up to 24.2% loss at 12 milligrams. Those are averages over a set time. Retatrutide is still experimental. A research-chemical vial is not the product used in the studies. Missed doses and diet changes are still the first questions, not about the drug, a clinician would ask. This FAQ does not invent a fade clock. Full record at /compounds/retatrutide.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.